Trained in TB research, Pakistani native Dr. Omar Vandal, Ph.D. ’07, now oversees Gates Foundation grants that save lives worldwide.
An investigation by Weill Cornell Medicine scientists has yielded two breakthroughs in the pursuit of combating growing resistance to tuberculosis treatments.
By sabotaging one of the tuberculosis bacterium’s defenses against antibiotics, Weill Cornell Medicine investigators may have found a way to accelerate treatment for the disease and possibly overcome growing resistance to existing therapies.
An experimental drug that blocks the activation of an immune cell component effectively prevented rejection of heart transplants in mice.
Back to News
Weill Cornell MedicineOffice of External Affairs
1300 York Ave.Box 314
New York, NY 10065
Phone: (646) 962-9564